Share
17,046 Posts.
lightbulb Created with Sketch. 2414
clock Created with Sketch. 30/04/24
17:57
Share
Originally posted by grussellt
↑
The share price movement today seems to suggest a bullish tone in the quarterly report..coupled with the new regulatorychanges around contrast agents being classified as drugs , and the feedback and advice received from the FDA, the Company has commenceddiscussions with drug manufacturers to find appropriate alternate pathways to resolve the issues raised by the Agency in relation to the novel topical use of fluorescein.
Expand
Yes, it appears that the game has changed with regard to approval of contrast agents. So instead of IV fluorescein they are looking a topical application instead to get past it? It's good though that they have engaged a specialist consultancy agency to walk them through this.
(20min delay)